Abstract
Lentigo maligna is a melanocytic neoplasm, often regarded as ‘melanoma in situ,’ which may progress to lentigo maligna melanoma. Lentigo maligna clinically presents as a pigmented, asymmetric macule that originates on the head and neck and spreads slowly. The preferred method for diagnosing lentigo maligna is excisional biopsy. Histology shows proliferation of atypical melanocytes at the epidermal–dermal junction in small nests or single cells. The differential diagnosis includes solar lentigo, seborrheic keratosis, lichen planus-like keratosis, pigmented actinic keratosis, and melanocytic nevus. Stains used in diagnosis include hematoxylin and eosin, HMB-45, MART-1/Melan-A, Mel-5, and S-100. Surgical excision is the preferred treatment for lentigo maligna. Second-line techniques include medical (topical imiquimod) and destructive therapy.
Similar content being viewed by others
References
Cohen LM. Lentigo maligna and lentigo maligna melanoma. J Am Acad Dermatol. 1995;33(6):923–36 (quiz 937–40. Erratum in: J Am Acad Dermatol. 1997 Jun;36(6 Pt 1):913. PubMed PMID: 7490362).
Newell GR, Sider JG, Bergfelt L, Kripke ML. Incidence of cutaneous melanoma in the United States by histology with special reference to the face. Cancer Res. 1988;48(17):5036–41.
Kuflik EG, Gage AA. Cryosurgery for lentigo maligna. J Am Acad Dermatol. 1994;31(1):75–8.
Dubreuilh MW. Lentigo malin des vieillards, Société de Dermatologie, 4 août, 1894.
Smalberger GJ, Siegel DM, Khachemoune A. Lentigo maligna. Dermatol Ther. 2008;21(6):439–46 (PubMed PMID: 19076621). doi:10.1111/j.1529-8019.2008.00244.x.
Al-Niaimi F, Jury CS, McLaughlin S, Herd RM. Review of management and outcome in 65 patients with lentigo maligna. Br J Dermatol. 2009;160(1):211–3. doi:10.1111/j.1365-2133.2008.08916.x (Epub 2008 Nov 11).
Situm M, Buljan M. Surgical and histologic pitfalls in the management of lentigo maligna melanoma. G Ital Dermatol Venereol. 2012;147(1):21–7 (PubMed PMID: 22370566).
Shiau CJ, Thompson JF, Scolyer RA. Controversies and evolving concepts in the diagnosis, classification and management of lentigo maligna. Exp Rev Dermatol. 2013;8(2):195–214. doi:10.1586/edm.13.17.
Dubow BE, Ackerman AB. Ideas in pathology: malignant melanoma in situ: the evolution of a concept. Mod Pathol. 1990;3:734–44.
Hendi A, Wada DA, Jacobs MA, Crook JE, Kortuem KR, Weed BR, Otley CC, Gibson LE. Melanocytes in nonlesional sun-exposed skin: a multicenter comparative study. J Am Acad Dermatol. 2011;65(6):1186–93. doi:10.1016/j.jaad.2010.10.039 (Epub 2011 Jun 17).
El Tal AK, Abrou AE, Stiff MA, Mehregan DA. Immunostaining in Mohs micrographic surgery: a review. Dermatol Surg. 2010;36:275–90.
Reed JA, Shea CR. Lentigo maligna: melanoma in situ on chronically sun-damaged skin. Arch Pathol Lab Med. 2011;135(7):838–41. doi:10.1043/2011-0051-RAIR.1 (PubMed PMID: 21732771).
El Shabrawi-Caelen L, Kerl H, Cerroni L. Melan-A: not a helpful marker in distinction between melanoma in situ on sun-damaged skin and pigmented actinic keratosis. Am J Dermatopathol. 2004;26(5):364–6.
Wiltz KL, Qureshi H, Patterson JW, et al. Immununostaining for MART-1 in the interpretation of problematic intraepidermal pigmented lesions. J Cutan Pathol. 2007;34:601–5.
Hendi A, Brodland DG, Zitelli JA. Melanocytes in long-standing sun-exposed skin. Arch Dermatol. 2006;142:871–6.
Cherpelis BS, Moore R, Ladd S, Chen R, Glass LF. Comparison of MART-1 frozen sections to permanent sections using a rapid 19-minute protocol. Dermatol Surg. 2009;35(2):207–13. doi:10.1111/j.1524-4725.2008.34411.x.
Paraskevas LR, Halpern AC, Marghoob AA. Utility of the Wood’s light: five cases from a pigmented lesion clinic. Br J Dermatol. 2005;152(5):1039–44.
Tanaka M, Sawada M, Kobayashi K. Key points in dermoscopic differentiation between lentigo maligna and solar lentigo. J Dermatol. 2011;38(1):53–8. doi:10.1111/j.1346-8138.2010.01132.x.
Schiffner R, Schiffner-Rohe J, Vogt T, Landthaler M, Wlotzke U, Cognetta AB, Stolz W. Improvement of early recognition of lentigo maligna using dermatoscopy. J Am Acad Dermatol. 2000;42(1 Pt 1):25–32.
Slutsky JB, Marghoob AA. The zig-zag pattern of lentigo maligna. Arch Dermatol. 2010;146(12):1444. doi:10.1001/archdermatol.2010.307.
Robinson JK. Use of digital epiluminescence microscopy to help define the edge of lentigo maligna. Arch Dermatol. 2004;140(9):1095–100.
Möller MG, Pappas-Politis E, Zager JS, Santiago LA, Yu D, Prakash A, Kinal A, Clark GS, Zhu W, Puleo CA, Glass LF, Messina JL, Sondak VK, Cruse CW. Surgical management of melanoma-in-situ using a staged marginal and central excision technique. Ann Surg Oncol. 2009;16(6):1526–36. doi:10.1245/s10434-008-0239-x (Epub 2008 Dec 3).
McKenna JK, Florell SR, Goldman GD, Bowen GM. Lentigo maligna/lentigo maligna melanoma: current state of diagnosis and treatment. Dermatol Surg. 2006;32(4):493–504 (PubMed PMID: 16681656).
Hazan C, Dusza SW, Delgado R, Busam KJ, Halpern AC, Nehal KS. Staged excision for lentigo maligna and lentigo maligna melanoma: a retrospective analysis of 117 cases. J Am Acad Dermatol. 2008;58(1):142–8 (Epub 2007 Oct 29).
Hilari H, Llorca D, Traves V, Villanueva A, Serra-Guillén C, Requena C, Llombart B, Sanmartín O, Guillén C, Nagore E. Conventional surgery compared with slow Mohs micrographic surgery in the treatment of lentigo maligna: a retrospective study of 62 cases. Actas Dermosifiliogr. 2012;103(7):614–23 (Epub 2012 May 7. English, Spanish. PubMed PMID: 22572575).
Abdelmalek M, Loosemore MP, Hurt MA, Hruza G. Geometric staged excision for the treatment of lentigo maligna and lentigo maligna melanoma: a long-term experience with literature review. Arch Dermatol. 2012;148(5):599–604. doi:10.1001/archdermatol.2011.2155.
Gaudy-Marqueste C, Perchenet AS, Taséi AM, Madjlessi N, Magalon G, Richard MA, Grob JJ. The “spaghetti technique”: an alternative to Mohs surgery or staged surgery for problematic lentiginous melanoma (lentigo maligna and acral lentiginous melanoma). J Am Acad Dermatol. 2011;64(1):113–8. doi:10.1016/j.jaad.2010.03.014.
Alarcón I, Carrera C, Puig S, Malvehy J. Clinical usefulness of reflectance confocal microscopy in the management of facial lentigo maligna melanoma. Actas Dermosifiliogr. 2013 (Epub ahead of print English, Spanish. PubMed PMID: 23642470). doi:10.1016/j.ad.2013.02.011.
Guitera P, Moloney FJ, Menzies SW, Stretch JR, Quinn MJ, Hong A, Fogarty G, Scolyer RA. Improving management and patient care in lentigo maligna by mapping with in vivo confocal microscopy. JAMA Dermatol. 2013;149(6):692–8. doi:10.1001/jamadermatol.2013.2301.
Nagore E, Botella-Estrada R. Imiquimod in the treatment of lentigo maligna. Actas Dermosifiliogr. 2011;102(8):559–62. doi:10.1016/j.ad.2011.03.003 (Epub 2011 May 4. Spanish).
Erickson C, Miller SJ. Treatment options in melanoma in situ: topical and radiation therapy, excision and Mohs surgery. Int J Dermatol. 2010;49:482–91.
Woodmansee CS, McCall MW. Recurrence of lentigo maligna and development of invasive melanoma after treatment of lentigo maligna with imiquimod. Dermatol Surg. 2009;35:1286–9.
Hedblad MA, Mallbris L. Grenz ray treatment of lentigo maligna and early lentigo maligna melanoma. J Am Acad Dermatol. 2012;67(1):60–8. doi:10.1016/j.jaad.2011.06.029 (Epub 2011 Oct 24).
Tsang RW, Liu FF, Wells W, Payne DG. Lentigo maligna of the head and neck: results of treatment by radiotherapy. Arch Dermatol. 1994;130(8):1008–12.
Harwood AR. Conventional radiotherapy in the treatment of lentigo maligna and lentigo maligna melanoma. J Am Acad Dermatol. 1982;6(3):310–6.
Schmid-Wendtner MH, Brunner B, Konz B, Kaudewitz P, Wendtner CM, Peter RU, Plewig G, Volkenandt M. Fractionated radiotherapy of lentigo maligna and lentigo maligna melanoma in 64 patients. J Am Acad Dermatol. 2000;43(3):477–82.
McLeod M, Franca K, Ferris K, Nouri K. Use of carbon dioxide laser to treat lentigo maligna and malignant melanoma in situ, lentigo maligna type. Arch Facial Plast Surg. 2012;14(6):462. doi:10.1001/archfacial.2012.874.
Huang CC. New approaches to surgery of lentigo maligna. Skin Therapy Lett. 2004;9(5):7–11 (PubMed PMID: 15146261).
Acknowledgments
There was no funding for the preparation of this manuscript.
Conflict of Interest Disclosure Statement
None of the authors have any conflicts of interest to declare.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kallini, J.R., Jain, S.K. & Khachemoune, A. Lentigo Maligna: Review of Salient Characteristics and Management. Am J Clin Dermatol 14, 473–480 (2013). https://doi.org/10.1007/s40257-013-0044-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40257-013-0044-6